COVID-19

Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of Death
Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of Death
Forbes
Gilead Sciences
pandemic
remdesivir
clinical trials
COVID-19
Flag link:
Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end
Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end
Reuters
BioNTech
Pfizer
COVID-19
vaccines
Flag link:
Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus
Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus
Fierce Pharma
Boehringer Ingelheim
COVID-19
antivirals
antibodies
Flag link:
Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions' of COVID-19 shot doses
Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions' of COVID-19 shot doses
Fierce Pharma
Moderna Therapeutics
MRNA
COVID-19
vaccines
Spain
Rovi
drug manufacturing
Flag link:
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
MedCity News
Gilead Sciences
remdesivir
NIH
COVID-19
Flag link:
In race to bring vaccine to market, big pharma struggles to protect its intellectual property rights
In race to bring vaccine to market, big pharma struggles to protect its intellectual property rights
CNBC
COVID-19
vaccines
intellectual property
Flag link:
Coronavirus Vaccine Race: Moderna or Vaxart?
Coronavirus Vaccine Race: Moderna or Vaxart?
Motley Fool
Moderna Therapeutics
Vaxart
COVID-19
vaccines
MRNA
mRNA-1273
oral vaccines
Flag link:
The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
Stat
Medicago
GSK
Dynavax
vaccines
COVID-19
Flag link:
Walgreens Suffers $700 Million Hit From Coronavirus ‘Stay At Home’ Orders
Walgreens Suffers $700 Million Hit From Coronavirus ‘Stay At Home’ Orders
Forbes
Walgreens Boots Alliance
Walgreens
pandemic
COVID-19
Flag link:
A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price
A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price
Stat
FDA
hydroxychloroquine
COVID-19
White House
clinical trials
Flag link:
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Forbes
Gilead Sciences
remdesivir
COVID-19
pandemic
clinical trials
Flag link:
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Fierce Pharma
Amgen
clinical trials
COVID-19
anti-TNF
Enbrel
Bob Bradway
Pharma CEOs
Flag link:
Moderna Completes Enrollment for Phase II Vaccine Trial
Moderna Completes Enrollment for Phase II Vaccine Trial
TheStreet.com
Moderna Therapeutics
clinical trials
vaccines
mRNA-1273
COVID-19
Flag link:
Digital Pharmacy Truepill Raises $25 Million To Expand Telehealth Offerings As Revenue Could Reach $200 Million This Year
Digital Pharmacy Truepill Raises $25 Million To Expand Telehealth Offerings As Revenue Could Reach $200 Million This Year
Forbes
Truepill
digital pharmacy
telehealth
pandemic
COVID-19
Flag link:
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Pharmaceutical Business Review
Corvus Pharmaceuticals
clinical trials
immunotherapy
COVID-19
CPI-006
Flag link:
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Fierce Pharma
Sanofi
Regeneron
Kevzara
clinical trials
COVID-19
Flag link:
Pharma's pandemic response could help attract tech talent, Novartis digital chief says
Pharma's pandemic response could help attract tech talent, Novartis digital chief says
Fierce Pharma
pharma industry
pandemic
COVID-19
Novartis
Flag link:
Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectables
Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectables
Fierce Pharma
Novartis
non-profits
Civica Rx
drug shortages
pandemic
COVID-19
Flag link:
GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine
GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine
BioSpace
GSK
Medicago
pandemic
COVID-19
vaccines
pandemic adjuvant system
Flag link:
Moderna spars with U.S. scientists over COVID-19 vaccine trials
Moderna spars with U.S. scientists over COVID-19 vaccine trials
Reuters
Moderna Therapeutics
COVID-19
vaccines
clinical trials
Flag link:

Pages